Ameriprise’s Cymabay Therapeutics CBAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-25,711
| Closed | -$607K | – | 3998 |
|
|
2023
Q4 | $607K | Buy |
+25,711
| New | +$458K | ﹤0.01% | 3372 |
|
|
2023
Q1 | – | Sell |
-11,561
| Closed | -$73K | – | 4053 |
|
|
2022
Q4 | $73K | Sell |
11,561
-6,950
| -38% | -$26.4K | ﹤0.01% | 3839 |
|
|
2022
Q3 | $65K | Sell |
18,511
-3,750
| -17% | -$13.5K | ﹤0.01% | 3873 |
|
|
2022
Q2 | $66K | Sell |
22,261
-1,400
| -6% | -$3.34K | ﹤0.01% | 3814 |
|
|
2022
Q1 | $74K | Buy |
23,661
+150
| +0.6% | +$472 | ﹤0.01% | 3865 |
|
|
2021
Q4 | $79K | Sell |
23,511
-9,134
| -28% | -$34.7K | ﹤0.01% | 3888 |
|
|
2021
Q3 | $120K | Sell |
32,645
-1,705
| -5% | -$6.72K | ﹤0.01% | 3766 |
|
|
2021
Q2 | $149K | Sell |
34,350
-1,275
| -4% | -$5.65K | ﹤0.01% | 3788 |
|
|
2021
Q1 | $161K | Sell |
35,625
-8,176
| -19% | -$44K | ﹤0.01% | 3729 |
|
|
2020
Q4 | $243K | Buy |
43,801
+12,105
| +38% | +$91.6K | ﹤0.01% | 3583 |
|
|
2020
Q3 | $229K | Buy |
31,696
+14,675
| +86% | +$78.5K | ﹤0.01% | 3501 |
|
|
2020
Q2 | $60K | Buy |
+17,021
| New | +$49.1K | ﹤0.01% | 3611 |
|
|
2019
Q4 | – | Sell |
-17,018
| Closed | -$87K | – | 3778 |
|
|
2019
Q3 | $87K | Buy |
17,018
+150
| +0.9% | +$908 | ﹤0.01% | 3640 |
|
|
2019
Q2 | $121K | Sell |
16,868
-911
| -5% | -$10.3K | ﹤0.01% | 3646 |
|
|
2019
Q1 | $236K | Buy |
17,779
+560
| +3% | +$5.96K | ﹤0.01% | 3508 |
|
|
2018
Q4 | $136K | Buy |
17,219
+1,740
| +11% | +$16.6K | ﹤0.01% | 3500 |
|
|
2018
Q3 | $171K | Buy |
15,479
+1,060
| +7% | +$13.2K | ﹤0.01% | 3567 |
|
|
2018
Q2 | $194K | Sell |
14,419
-74,166
| -84% | -$928K | ﹤0.01% | 3497 |
|
|
2018
Q1 | $1.15M | Sell |
88,585
-78,959
| -47% | -$981K | ﹤0.01% | 2919 |
|
|
2017
Q4 | $1.54M | Sell |
167,544
-22,956
| -12% | -$196K | ﹤0.01% | 2787 |
|
|
2017
Q3 | $1.54M | Buy |
+190,500
| New | +$1.29M | ﹤0.01% | 2748 |
|